S

Sutter Health | Palo Alto Medical Foundation

Research site

(Unclaimed)

Location

795 El Camino Real, Palo Alto, California, United States of America

Site insights

Top conditions

Top treatments

Carboplatin

Bevacizumab

Paclitaxel

Chemo

fluorouracil

Tamoxifen Citrate

Oxaliplatin

Rosuvastatin

cyclophosphamide

Trastuzumab

Parent organization

This site is a part of Sutter Health

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 35 total trials

Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach

Purpose is to study the clinical outcomes of Clareon Vivity and Clareon Vivity Toric intraocular lens (IOL) implants in patients who are planning to...

Active, not recruiting

Aphakia, Postcataract

Device: Clareon Vivity and Clareon Vivity Toric IOLs targeted for mini-monovision with dominant eye set at emmetropia and non-dominant eye at -0.50.

PATHFINDER 2: A Multi-Cancer Early Detection Study

This is a prospective, multi-center interventional study of the GRAIL multi-cancer early detection (MCED) test with return of test results for partic...

Active, not recruiting

Early Detection of Cancer

Cancer

Device: Multi-Cancer Early Detection Test

Locations recently updated

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) (DO-01)

This clinical trial is designed to evaluate the efficacy and safety of T-DXd in combination with bevacizumab versus bevacizumab monotherapy as first-...

Enrolling

Ovarian Cancer

Drug: Trastuzumab Deruxtecan

Drug: Bevacizumab